• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Fluticasone/salmeterol     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:TradeName106845599, within Data Space : dbpedia.org associated with source document(s)

Type: Thingdul:ChemicalObjectchemical substanceDrugyago:WikicatAntiasthmaticDrugscombination drugyago:WikicatCombinationDrugsyago:Abstraction100002137yago:Agent114778436yago:CausalAgent100007347yago:Drug103247620yago:LanguageUnit106284225yago:Matter100020827yago:Name106333653yago:Part113809207yago:PhysicalEntity100001930yago:Relation100031921yago:WikicatGlaxoSmithKlineBrandsdrugyago:Substance100020090yago:TradeName106845599 New Facet based on Instances of this Class

Fluticasone/salmeterol, sold under the brand name Advair among others, is a fixed-dose combination medication containing fluticasone propionate and salmeterol. It is used in the management of asthma and chronic obstructive pulmonary disease (COPD). It is used by inhaling the medication into the lungs. The combination was approved for medical use in the United States in 2000. A generic version was approved in the United States in 2019. In 2020, it was the 56th most commonly prescribed medication in the United States, with more than 11 million prescriptions.